Phase 3 targets to complete next Sep. The 3 therapeutics are still in preclinical with universities. Oral covid vaccine is also in preclinical. I am afraid AEZS share price will still be under pressure even those 4 preclinicals start phase I…what’s your view on timeline on share price?